Importantly, here, for the first time, it is demonstrated that si-m/hVDAC1-B reached the lung tumor, inhibited tumor growth of both small and non-small lung cancer and led to metabolism reprogramming and a decrease in the presence of CSCs, as reflected in the decreased expression of the CD44 and CD133 markers. The gene discussed is PROM1; the disease is neoplasm.